https://www.selleckchem.com/pr....oducts/halofuginone.
People with HIV are disproportionately co-infected with hepatitis C virus (HCV) and experience accelerated liver-related mortality. Direct-acting antivirals (DAAs) yield high sustained virologic response (SVR) rates, but uptake is suboptimal. This study characterizes the DAA-era HCV treatment cascade and barriers among US men and women with or at risk for HIV. We constructed HCV treatment cascades using data from The Women's Interagency HIV Study (women, six visits, 2015-2018, n=2,447) and Multicenter AIDS Cohort Study (men, one vi
Like
Comment
Share
